President Donald Trump's second administration, unlike his first, hasn't had a lot of turnover — as Trump has made a point of surrounding himself with ultra-MAGAPresident Donald Trump's second administration, unlike his first, hasn't had a lot of turnover — as Trump has made a point of surrounding himself with ultra-MAGA

Young Republicans driving 'revolt against the MAGA establishment'

2026/03/19 01:31
3 min read
For feedback or concerns regarding this content, please contact us at crypto.news@mexc.com

President Donald Trump's second administration, unlike his first, hasn't had a lot of turnover — as Trump has made a point of surrounding himself with ultra-MAGA loyalists this time. But a far-right MAGA Republican, Joe Kent, sent shockwaves through the administration when, on Tuesday, March 17, he expressed his disdain for the Iran war by abruptly announcing that he was leaving his position as director of the National Counterterrorism Center.

In his resignation letter, Kent wrote, "I cannot in good conscience support the ongoing war in Iran. Iran posed no imminent threat to our nation, and it is clear that we started this war due to pressure from Israel and its powerful American lobby…. I cannot support sending the next generation off to fight and die in a war that serves no benefit to the American people nor justifies the cost of American lives."

In an article published by the conservative website The Bulwark on March 18, journalist Andrew Egger stresses that the importance of Kent's resignation goes way beyond Kent himself — as it underscores a "revolt against the MAGA establishment." And much of the revolt, according to Egger is coming from younger American First Republicans.

"The more interesting point now is that (Kent) sees political promise in turning on Trump at all," Egger argues. "For a while, it's been clear that Trump — for all the chaos of his administration and for all his explosive hatred of the liberal establishment — now fully embodies a GOP establishment of his own. These days, your median empty-suit Republican congressman is more likely to make embracing Trump his entire personality than actual internet-poisoned true believers of the MAGA base are. Now, we're starting to see the corollary development: shades of MAGA countercultural revolt against that MAGA establishment."

Egger continues, "With a few exceptions — Tucker Carlson being the most obvious —you see this primarily among younger, smaller stars in Trumpworld. If you have a small right-wing following and you're looking to make it a big right-wing following, and most especially if that following is concentrated among young right-wing people, it's no longer the case that backing Trump to the hilt is the only move."

The Bulwark journalist notes that Carrie Prejean Boller, a MAGA influencer who Trump appointed to his Religious Liberty Commission, "tripled her social-media following after provoking Trump into firing her" by "demanding to know if other commissioners thought her anti-Israel positions made her an antisemite."

"There's no reason to believe that the MAGA base broadly opposes Trump's war in Iran; Trump's voters have always been more blandly fine with Trump's wars than the doves in MAGA media would like to believe," Egger adds. "But the anti-war and anti-Israel types, who are disproportionately young, have established a beachhead in the Republican coalition. Joe Kent won't be the last would-be right-wing star to flee Trump in a play for their support."

  • george conway
  • noam chomsky
  • civil war
  • Kayleigh mcenany
  • Melania trump
  • drudge report
  • paul krugman
  • Lindsey graham
  • Lincoln project
  • al franken bill maher
  • People of praise
  • Ivanka trump
  • eric trump
Market Opportunity
OFFICIAL TRUMP Logo
OFFICIAL TRUMP Price(TRUMP)
$3.492
$3.492$3.492
+1.54%
USD
OFFICIAL TRUMP (TRUMP) Live Price Chart
Disclaimer: The articles reposted on this site are sourced from public platforms and are provided for informational purposes only. They do not necessarily reflect the views of MEXC. All rights remain with the original authors. If you believe any content infringes on third-party rights, please contact crypto.news@mexc.com for removal. MEXC makes no guarantees regarding the accuracy, completeness, or timeliness of the content and is not responsible for any actions taken based on the information provided. The content does not constitute financial, legal, or other professional advice, nor should it be considered a recommendation or endorsement by MEXC.

You May Also Like

Michael Saylor Pushes Digital Capital Narrative At Bitcoin Treasuries Unconference

Michael Saylor Pushes Digital Capital Narrative At Bitcoin Treasuries Unconference

The post Michael Saylor Pushes Digital Capital Narrative At Bitcoin Treasuries Unconference appeared on BitcoinEthereumNews.com. The suitcoiners are in town.  From a low-key, circular podium in the middle of a lavish New York City event hall, Strategy executive chairman Michael Saylor took the mic and opened the Bitcoin Treasuries Unconference event. He joked awkwardly about the orange ties, dresses, caps and other merch to the (mostly male) audience of who’s-who in the bitcoin treasury company world.  Once he got onto the regular beat, it was much of the same: calm and relaxed, speaking freely and with confidence, his keynote was heavy on the metaphors and larger historical stories. Treasury companies are like Rockefeller’s Standard Oil in its early years, Michael Saylor said: We’ve just discovered crude oil and now we’re making sense of the myriad ways in which we can use it — the automobile revolution and jet fuel is still well ahead of us.  Established, trillion-dollar companies not using AI because of “security concerns” make them slow and stupid — just like companies and individuals rejecting digital assets now make them poor and weak.  “I’d like to think that we understood our business five years ago; we didn’t.”  We went from a defensive investment into bitcoin, Saylor said, to opportunistic, to strategic, and finally transformational; “only then did we realize that we were different.” Michael Saylor: You Come Into My Financial History House?! Jokes aside, Michael Saylor is very welcome to the warm waters of our financial past. He acquitted himself honorably by invoking the British Consol — though mispronouncing it, and misdating it to the 1780s; Pelham’s consolidation of debts happened in the 1750s and perpetual government debt existed well before then — and comparing it to the gold standard and the future of bitcoin. He’s right that Strategy’s STRC product in many ways imitates the consols; irredeemable, perpetual debt, issued at par, with…
Share
BitcoinEthereumNews2025/09/18 02:12
Trump White House Registers Aliens.gov—Is the UFO File Drop Imminent?

Trump White House Registers Aliens.gov—Is the UFO File Drop Imminent?

The post Trump White House Registers Aliens.gov—Is the UFO File Drop Imminent? appeared on BitcoinEthereumNews.com. In brief The White House registered aliens.gov
Share
BitcoinEthereumNews2026/03/19 05:33
Non-Opioid Painkillers Have Struggled–Cannabis Drugs Might Be The Solution

Non-Opioid Painkillers Have Struggled–Cannabis Drugs Might Be The Solution

The post Non-Opioid Painkillers Have Struggled–Cannabis Drugs Might Be The Solution appeared on BitcoinEthereumNews.com. In this week’s edition of InnovationRx, we look at possible pain treatments from cannabis, risks of new vaccine restrictions, virtual clinical trials at the Mayo Clinic, GSK’s $30 billion U.S. manufacturing commitment, and more. To get it in your inbox, subscribe here. Despite their addictive nature, opioids continue to be a major treatment for pain due to a lack of effective alternatives. In an effort to boost new drugs, the FDA released new guidelines for non-opioid painkillers last week. But making these drugs hasn’t been easy. Vertex Pharmaceuticals received FDA approval for its non-opioid Journavx in January, then abandoned a next generation drug after a failed clinical trial earlier this summer. Acadia similarly abandoned a promising candidate after a failed trial in 2022. One possible basis for non-opioids might be cannabis. Earlier this year, researchers at Washington University at St. Louis and Stanford published a study showing that a cannabis-derived compound successfully eased pain in mice with minimal side effects. Munich-based pharmaceutical company Vertanical is perhaps the furthest along in this quest. It is developing a cannabinoid-based extract to treat chronic pain it hopes will soon become an approved medicine, first in the European Union and eventually in the United States. The drug, currently called Ver-01, packs enough low levels of cannabinoids (including THC) to relieve pain, but not so much that patients get high. Founder Clemens Fischer, a 50-year-old medical doctor and serial pharmaceutical and supplement entrepreneur, hopes it will become the first cannabis-based painkiller prescribed by physicians and covered by insurance. Fischer founded Vertanical, with his business partner Madlena Hohlefelder, in 2017, and has invested more than $250 million of his own money in it. With a cannabis cultivation site and drug manufacturing plant in Denmark, Vertanical has successfully passed phase III clinical trials in Germany and expects…
Share
BitcoinEthereumNews2025/09/18 05:26